https://doi.org/10.1136/bmjopen-2019-035416
M
Makoto Hori
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
294
Papers
4.0K
Citations
34
h-index
105
i10-index
Makoto Hori is an academic researcher from Chiba University Hospital. The author has contributed to research in topics: Microbial Natural Products and Biosynthesis & Antibiotics Pharmacokinetics and Efficacy & RNA and protein synthesis mechanisms. The author has an h-index of 34, co-authored 250 publications.
Papers by this author
worksMedroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)
2020 · BMJ Open · 33 citations
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial
2021 · Trials · 19 citations
https://doi.org/10.1186/s13063-021-05282-w
Incidence of skin cancer among Nagasaki atomic bomb survivors. Preliminary report.
1990 · Journal of Radiation Research · 3 citations
https://doi.org/10.1269/jrr.31.280
LCAT-trial-24 weeks: Protocol for a clinical study to evaluate the safety of regenerative medicine and gene therapy by the autologous transplantation of human lecithin:cholesterol acyltransferase gene-transduced human pre-adipocytes
2022 · Contemporary Clinical Trials Communications · 1 citations
https://doi.org/10.1016/j.conctc.2022.100946
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat